Form 4: National Vision Holdings SVP VanDette Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Joseph VanDette, SVP and Chief Marketing Officer of National Vision Holdings, reports the acquisition and disposal of common stock and restricted stock units.

Summary

  • On March 1, 2025, Joseph VanDette exercised 3,363 restricted stock units (RSUs) and sold 1,179 shares of common stock at $12.71 to cover tax obligations.
  • Following these transactions on March 1, 2025, VanDette directly owns 10,444 shares of common stock and 21,258 RSUs.
  • On March 3, 2025, VanDette exercised 6,350 RSUs and sold 2,140 shares of common stock at $12.66 to cover tax obligations.
  • Following these transactions on March 3, 2025, VanDette directly owns 14,654 shares of common stock and 14,908 RSUs.
  • The RSUs convert into common stock on a one-for-one basis and vest in three equal installments beginning on the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common for executives who receive stock-based compensation. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the increased number of shares in the market, but the effect is likely minimal given the relatively small volume of shares involved.

Key Dates

DateDescription
03/03/2023Reporting person was granted 19,050 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.
03/01/2024Reporting person was granted 10,090 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.
03/01/2025Date of transaction involving the exercise of 3,363 restricted stock units and sale of 1,179 shares of common stock.
03/03/2025Date of transaction involving the exercise of 6,350 restricted stock units and sale of 2,140 shares of common stock.
03/04/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.